Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 6.13% is 72% below its 5-year average of 21.94%, around the middle of its 5-year range (-29.72%–38.49%).
268.63% above its 12-month average of 1.66%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 16.46%.
EBITDA MARGIN
6.13%
EBITDA MARGIN AVG TTM
1.66%
EBITDA MARGIN AVG 3Y
16.43%
EBITDA MARGIN AVG 5Y
21.94%
EBITDA MARGIN AVG 10Y
26.75%
EBITDA MARGIN AVG 15Y
20.72%
EBITDA MARGIN AVG 20Y
-18.30%
CURRENT VS TTM AVG
+268.63%
CURRENT VS 3Y AVG
-62.69%
CURRENT VS 5Y AVG
-72.06%
CURRENT VS 10Y AVG
-77.08%
CURRENT VS 15Y AVG
-70.41%
CURRENT VS 20Y AVG
+133.51%
Corcept Therapeutics Incorporated
Market Cap
$13.19B
EBITDA Margin
6.13%
TTM Avg
1.66%
3Y Avg
16.43%
5Y Avg
21.94%
Market Cap
$12.95B
EBITDA Margin
-111.55%
TTM Avg
-188.02%
3Y Avg
-1871.48%
5Y Avg
-2339.83%
Market Cap
$12.89B
EBITDA Margin
16.91%
TTM Avg
18.03%
3Y Avg
18.32%
5Y Avg
17.35%
Market Cap
$12.52B
EBITDA Margin
5.99%
TTM Avg
7.75%
3Y Avg
3.55%
5Y Avg
8.89%
Market Cap
$14.16B
EBITDA Margin
-16.47%
TTM Avg
-44.13%
3Y Avg
-328.90%
5Y Avg
-1924.25%
Market Cap
$12.17B
EBITDA Margin
3.56%
TTM Avg
3.60%
3Y Avg
4.06%
5Y Avg
4.82%
Market Cap
$12.00B
EBITDA Margin
23.27%
TTM Avg
22.46%
3Y Avg
26.66%
5Y Avg
22.37%
Market Cap
$14.64B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corcept Therapeutics Incorporated (CORT) | $13.19B | 6.13% | 1.66% | 16.43% | 21.94% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -111.55% | -188.02% | -1871.48% | -2339.83% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 16.91% | 18.03% | 18.32% | 17.35% |
| Baxter International Inc. (BAX)vs › | $12.52B | 5.99% | 7.75% | 3.55% | 8.89% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 14.73% | 11.96% | 9.26% | 5.60% |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | -16.47% | -44.13% | -328.90% | -1924.25% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 3.56% | 3.60% | 4.06% | 4.82% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 23.27% | 22.46% | 26.66% | 22.37% |
| Tempus AI, Inc. (TEM)vs › | $14.64B | -11.84% | -53.07% | -52.51% | -64.32% |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 38.84% | 34.03% | 26.26% | 22.70% |
Gross Margin
98.3%
EBITDA Margin
6.1%
Operating Margin
0.8%
Net Margin
6.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 16.46% |
| 2026-03-31 | -29.72% |
| 2025-12-31 | 2.46% |
| 2025-09-30 | 5.15% |
| 2025-06-30 | 13.96% |
| 2025-03-31 | 2.47% |
| 2024-12-31 | 14.14% |
| 2024-09-30 | 25.80% |
| 2024-06-30 | 21.89% |
| 2024-03-31 | 20.18% |
| 2023-12-31 | 23.81% |
| 2023-09-30 | 25.46% |
| 2023-06-30 | 25.39% |
| 2023-03-31 | 14.33% |
| 2022-12-31 | 22.56% |
| 2022-09-30 | 32.13% |
| 2022-06-30 | 31.05% |
| 2022-03-31 | 29.43% |
| 2021-12-31 | 37.91% |
| 2021-09-30 | 38.49% |
| 2021-06-30 | 35.70% |
| 2021-03-31 | 25.66% |
| 2020-12-31 | 36.24% |
| 2020-09-30 | 29.29% |
| 2020-06-30 | 40.39% |
| 2020-03-31 | 41.09% |
| 2019-12-31 | 40.48% |
| 2019-09-30 | 41.20% |
| 2019-06-30 | 34.82% |
| 2019-03-31 | 30.03% |
| 2018-12-31 | 37.36% |
| 2018-09-30 | 35.73% |
| 2018-06-30 | 33.21% |
| 2018-03-31 | 36.50% |
| 2017-12-31 | 40.81% |
| 2017-09-30 | 31.94% |
| 2017-06-30 | 36.01% |
| 2017-03-31 | 17.22% |
| 2016-12-31 | 21.09% |
| 2016-09-30 | 14.24% |
| 2016-06-30 | 7.77% |
| 2016-03-31 | 3.85% |
| 2015-12-31 | 11.22% |
| 2015-09-30 | 1.00% |
| 2015-06-30 | -9.28% |
| 2015-03-31 | -39.50% |
| 2014-12-31 | -33.73% |
| 2014-09-30 | -69.54% |
| 2014-06-30 | -111.84% |
| 2014-03-31 | -291.28% |
| 2013-12-31 | -243.23% |
| 2013-09-30 | -369.02% |
| 2013-06-30 | -569.22% |
| 2013-03-31 | -636.52% |
| 2012-12-31 | -724.47% |
| 2012-09-30 | -725.69% |
| 2012-06-30 | -867.09% |
| 2009-12-31 | 516100.00% |
| 2009-09-30 | -455.32% |
| 2009-06-30 | -81333.33% |
| 2009-03-31 | -23045.83% |
| 2008-12-31 | -4206.29% |
| 2008-09-30 | -7422.73% |
| 2007-06-30 | -421.39% |
| 2007-03-31 | -2430.56% |
| 2006-12-31 | -5461.64% |
| 2006-06-30 | -8060.00% |
| 2006-03-31 | -5765.29% |
